Literature DB >> 15496581

Physiological roles of SAPK/JNK signaling pathway.

Hiroshi Nishina1, Teiji Wada, Toshiaki Katada.   

Abstract

Stress-activated protein kinase/c-Jun NH(2)-terminal kinase (SAPK/JNK) is activated by many types of cellular stresses and extracellular signals. Recent studies, including the analysis with knockout mice, have led to progress towards understanding the physiological roles of SAPK/JNK activation in embryonic development in addition to immune responses. SAPK/JNK activation plays essential roles in organogenesis during mouse development by regulating cell survival, apoptosis, and proliferation. Two SAPK/JNK activators, SEK1 and MKK7, are required for fetal liver formation and full activation of SAPK/JNK, which responds to various stimuli in an all-or-none manner. This article focuses on physiological roles of SAPK/JNK activation in fetal liver formation and in apoptosis regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496581     DOI: 10.1093/jb/mvh117

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  36 in total

1.  2-Phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c-Jun N-terminal kinase.

Authors:  Wei-Ling Chang; Chih-Shiang Chang; Po-Cheng Chiang; Yunn-Fang Ho; Ju-Fang Liu; Kai-Wei Chang; Jih-Hwa Guh
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.

Authors:  Thomas H Beckham; Saeed Elojeimy; Joseph C Cheng; Lorianne S Turner; Stanley R Hoffman; James S Norris; Xiang Liu
Journal:  Expert Opin Ther Targets       Date:  2010-05       Impact factor: 6.902

3.  p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target.

Authors:  Narayan R Bhat; Peisheng Zhang; Sangeeta B Mohanty
Journal:  Neurochem Res       Date:  2007-01-19       Impact factor: 3.996

4.  MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress.

Authors:  Yan Xia; Ji Wang; Shuichan Xu; Gary L Johnson; Tony Hunter; Zhimin Lu
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

5.  Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation.

Authors:  Daiju Kitagawa; Hiroaki Kajiho; Takahiro Negishi; Seiji Ura; Tomomi Watanabe; Teiji Wada; Hidenori Ichijo; Toshiaki Katada; Hiroshi Nishina
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

6.  Interaction of ARC and Daxx: A Novel Endogenous Target to Preserve Motor Function and Cell Loss after Focal Brain Ischemia in Mice.

Authors:  Stefan Donath; Junfeng An; Sabrina Lin Lin Lee; Karen Gertz; Anna Lena Datwyler; Ulrike Harms; Susanne Müller; Tracy Deanne Farr; Martina Füchtemeier; Gisela Lättig-Tünnemann; Janet Lips; Marco Foddis; Larissa Mosch; René Bernard; Ulrike Grittner; Mustafa Balkaya; Golo Kronenberg; Ulrich Dirnagl; Matthias Endres; Christoph Harms
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

7.  Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain.

Authors:  Zenshi Miyake; Mutsuhiro Takekawa; Qingyuan Ge; Haruo Saito
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

Review 8.  Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades.

Authors:  Z Yang; L Song; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

9.  Activation by phosphorylation and purification of human c-Jun N-terminal kinase (JNK) isoforms in milligram amounts.

Authors:  Anastasia F Thévenin; Chati L Zony; Brian J Bahnson; Roberta F Colman
Journal:  Protein Expr Purif       Date:  2010-08-13       Impact factor: 1.650

10.  Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.